Exclusive special offer and discount title banner vector image

EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET FORECAST 2023-2032

SCOPE OF THE REPORT

Europe Neurovascular Devices / Interventional Neurology Market by Product (Embolization Devices, Accessory Devices, Revascularization Devices, Thrombectomy Devices, Embolic Protection Devices) Market by Application (Aneurysm, Ischemic Stroke, Stenosis, Arteriovenous Malformation, Other Applications) by Geography

REQUEST CUSTOMIZATION

MARKET OVERVIEW

The Europe neurovascular devices/interventional neurology market is predicted to grow with a CAGR of 5.01% during the forecast period of 2023 to 2032, acquiring a revenue share of $1420.79 million by 2032.

Some of the leading factors accredited to the regional market’s growth include the older population’s high susceptibility to neurological illnesses, such as strokes and vascular disorders, in addition to the advent of telemedicine and teleconsultation services, especially in rural or underserved areas. However, the Europe neurovascular devices/interventional neurology market may be hindered by the expensive price of neurovascular devices, as well as changes in healthcare priorities and budget allocation owing to the COVID-19 pandemic.

Europe Neurovascular Devices Interventional Neurology Market

To Know More About This Report, Request a Free Sample Copy

The Europe neurovascular devices/interventional neurology market growth evaluation encompasses the analysis of the United Kingdom, Germany, France, Italy, Spain, Poland, Belgium, and Rest of Europe. In the United Kingdom, significant advancements in neuro-interventional technologies have emerged, aiming to improve procedure safety, expand the scope of successfully treatable neurovascular conditions, and enhance patient outcomes. Moreover, the development of robotic systems has played a crucial role in neuro-interventional procedures, providing enhanced control and stability during device manipulation. These robotic systems not only reduce radiation exposure but also improve procedural precision and interventionalists’ skills.

On the other hand, Germany is facing a notable surge in the incidence of neurological illnesses, presenting the healthcare system with various challenges, including the demand for specialized neurological care, diagnostic services, and effective treatments. Furthermore, brain and central nervous system tumors constitute 25% of all cancer diagnoses in young individuals, as reported by the German Brain Tumor Association in 2020. Additionally, a study conducted by Peige Songs in Germany, published in the Journal of Global Health in February 2021, revealed a lifetime prevalence of 4.8% for Attention-deficit/hyperactivity disorder (ADHD) diagnosis. 

The study also highlighted a significant gender discrepancy, with boys at 7.7% and girls at 1.8%, indicating a potential rise in demand for neurology devices to address this increasing prevalence of ADHD. Moreover, according to Globocan 2020, an estimated 7,697 cases of brain and central nervous system cancer were projected for Germany in 2020, with a 5-year prevalence of 23,889 cases. These alarming statistics underscore the growing need for neurology devices in the country to cater to the high prevalence rate of neurological illnesses. Hence, the aforementioned factors are expected to drive the Europe neurovascular devices/interventional neurology market growth during the forecasting period.

The Europe neurovascular devices/interventional neurology market is segmented into product and application. The product segment includes embolization device, accessory device, revascularization device, thrombectomy device, and embolic protection device.

Accessory devices play a crucial role in supplementing, supporting, or enhancing the performance of parent neurovascular devices. In this regard, microcatheters and micro-guidewires are essential accessory devices used to direct other neurovascular devices to their intended target sites. These devices hold immense importance in neurovascular interventions, facilitating precise and efficient procedures. The benefits offered by these accessory devices include their ease of supplementation, small size, and simple detachment,

Leading firms operating in the Europe neurovascular devices/interventional neurology market include Acandis GmbH, Phenox Inc, etc.

Acandis GmbH, headquartered in Germany, is a medical device company focused on the prevention as well as treatment of stroke. The company manufactures, develops, and markets products for neurovascular diseases such as intracranial aneurysms, intracranial stenosis, and ischemic strokes. It also offers training and services (with a particular sizing tool, which enables the exact measurement of different vessel geometries) for interventional neuroradiology.

REPORT SYNOPSIS

REPORT SCOPEDETAILS
Market Forecast Years2023-2032
Base Year2022
Market Historical Years2018-2022
Forecast UnitsRevenue ($ Million)
Segments Analyzed
Product and Application
Countries AnalyzedThe United Kingdom, Germany, France, Italy, Spain, Poland, Belgium, and Rest of Europe
Companies AnalyzedAcandis GmbH, Asahi Intecc, B Braun Melsungen AG, Balt, Integer Holdings Corporation, Johnson & Johnson (Cerenovus), Kaneka Corporation, Medtronic Inc, Memry Corporation, MicroPort Scientific Corporation, Penumbra Inc, Phenox Inc, Rapid Medical, Stryker Corporation, Terumo Corporation, Sensome

TABLE OF CONTENT

  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. METHODOLOGY
    3. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. MARKET OVERVIEW
    3. SCOPE OF STUDY
    4. CRISIS SCENARIO ANALYSIS
      1. IMPACT OF COVID-19 ON NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET
    5. MAJOR MARKET FINDINGS
      1. GOVERNMENT INITIATIVES TO CREATE AWARENESS ABOUT NEUROVASCULAR DISEASES
      2. EARLY DETECTION OF ARTERIOVENOUS MALFORMATION (AVM)
      3. THROMBECTOMY IMPROVES PATIENT OUTCOMES AND REDUCES DISABILITY RATE
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. SIGNIFICANT RISE IN INCIDENCE OF NEUROVASCULAR CONDITIONS 
      2. PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES
      3. GERIATRIC POPULATION’S VULNERABILITY TO NEUROVASCULAR DISEASES
      4. UNDERLYING DISEASES ARE A RISK FACTOR FOR NEUROVASCULAR DISEASES
    2. KEY RESTRAINTS
      1. EXORBITANT COSTS OF NEUROVASCULAR DEVICES
      2. LACK OF TRAINED NEUROSURGEONS
  4. KEY ANALYTICS
    1. KEY MARKET TRENDS
    2. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTION
      4. NEW ENTRANTS
      5. INDUSTRY RIVALRY
    3. GROWTH PROSPECT MAPPING
      1. GROWTH PROSPECT MAPPING FOR UNITED KINGDOM
    4. MARKET CONCENTRATION ANALYSIS
    5. VALUE CHAIN ANALYSIS
  5. MARKET BY PRODUCT
    1. EMBOLIZATION DEVICES
      1. EMBOLIC COILS
        1. COATED DETACHABLE COILS
        2. BARE DETACHABLE COILS
      2. COIL ASSIST STENT
      3. CLIPPINGS
      4. COIL ASSIST BALLOON
    2. ACCESSORY DEVICES
      1. MICROCATHETERS
      2. MICRO GUIDEWIRES
    3. REVASCULARIZATION DEVICES
      1. CAROTID ARTERY STENTS
      2. FLOW DIVERSION STENTS
    4. THROMBECTOMY DEVICES
      1. CLOT RETRIEVAL DEVICES
      2. SUCTION AND ASPIRATION DEVICES
      3. SNARES
    5. EMBOLIC PROTECTION DEVICES
      1. BALLOON OCCLUSION DEVICES
      2. DISTAL FILTER DEVICES
  6. MARKET BY APPLICATION
    1. ANEURYSM
    2. ISCHEMIC STROKE
    3. STENOSIS
    4. ARTERIOVENOUS MALFORMATION (AVM)
    5. OTHER APPLICATIONS
  7. GEOGRAPHICAL ANALYSIS
    1. EUROPE
      1. MARKET SIZE & ESTIMATES
      2. EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET DRIVERS
      3. EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET CHALLENGES
      4. EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET REGULATORY FRAMEWORK
      5. KEY PLAYERS IN EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET
      6. COUNTRY ANALYSIS
        1. UNITED KINGDOM
          1. UNITED KINGDOM NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
        2. GERMANY
          1. GERMANY NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
        3. FRANCE
          1. FRANCE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
        4. ITALY
          1. ITALY NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
        5. SPAIN
          1. SPAIN NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
        6. POLAND
          1. POLAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
        7. BELGIUM
          1. BELGIUM NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
        8. REST OF EUROPE
          1. REST OF EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
  8. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. MERGERS & ACQUISITIONS
      2. PRODUCT LAUNCHES & DEVELOPMENTS
      3. PARTNERSHIPS & AGREEMENTS
      4. BUSINESS EXPANSIONS & DIVESTITURES
    2. COMPANY PROFILES
      1. ACANDIS GMBH
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
      2. ASAHI INTECC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST 
      3. BALT
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
      4. B BRAUN MELSUNGEN AG
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      5. INTEGER HOLDINGS CORPORATION
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      6. JOHNSON & JOHNSON (CERENOVUS)
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      7. KANEKA CORPORATION
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
      8. MEDTRONIC INC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      9. MEMRY CORPORATION
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
      10. MICROPORT SCIENTIFIC CORPORATION
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      11. PENUMBRA INC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
      12. PHENOX INC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      13. RAPID MEDICAL
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      14. SENSOME
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      15. STRYKER CORPORATION
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      16. TERUMO CORPORATION
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY

TABLE 2: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 3: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY PRODUCT, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 4: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIZATION DEVICES, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 5: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIZATION DEVICES, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 6: EUROPE EMBOLIZATION DEVICES MARKET, BY EMBOLIC COILS, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 7: EUROPE EMBOLIZATION DEVICES MARKET, BY EMBOLIC COILS, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 8: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY ACCESSORY DEVICES, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 9: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY ACCESSORY DEVICES, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 10: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY REVASCULARIZATION DEVICES, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 11: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY REVASCULARIZATION DEVICES, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 12: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY THROMBECTOMY DEVICES, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 13: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY THROMBECTOMY DEVICES, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 14: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIC PROTECTION DEVICES, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 15: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIC PROTECTION DEVICES, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 16: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 17: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY APPLICATION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 18: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 19: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 20: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET REGULATORY FRAMEWORK

TABLE 21: KEY PLAYERS OPERATING IN EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET

TABLE 22: LIST OF MERGERS & ACQUISITIONS

TABLE 23: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 24: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 25: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES 

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: GROWTH PROSPECT MAPPING FOR UNITED KINGDOM

FIGURE 4: MARKET CONCENTRATION ANALYSIS

FIGURE 5: VALUE CHAIN ANALYSIS

FIGURE 6: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2022

FIGURE 7: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIZATION DEVICES, 2023-2032 (IN $ MILLION)

FIGURE 8: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY EMBOLIZATION DEVICES, IN 2022

FIGURE 9: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIC COILS, 2023-2032 (IN $ MILLION)

FIGURE 10: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY EMBOLIC COILS, IN 2022

FIGURE 11: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COATED DETACHABLE COILS, 2023-2032 (IN $ MILLION)

FIGURE 12: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY BARE DETACHABLE COILS, 2023-2032 (IN $ MILLION)

FIGURE 13: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COIL ASSIST STENT, 2023-2032 (IN $ MILLION)

FIGURE 14: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY CLIPPINGS, 2023-2032 (IN $ MILLION)

FIGURE 15: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COIL ASSIST BALLOON, 2023-2032 (IN $ MILLION)

FIGURE 16: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY ACCESSORY DEVICES, 2023-2032 (IN $ MILLION)

FIGURE 17: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY ACCESSORY DEVICES, IN 2022

FIGURE 18: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY MICROCATHETERS, 2023-2032 (IN $ MILLION)

FIGURE 19: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY MICRO GUIDEWIRES, 2023-2032 (IN $ MILLION)

FIGURE 20: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY REVASCULARIZATION DEVICES, 2023-2032 (IN $ MILLION)

FIGURE 21: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY REVASCULARIZATION DEVICES, IN 2022

FIGURE 22: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY CAROTID ARTERY STENTS, 2023-2032 (IN $ MILLION)

FIGURE 23: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY FLOW DIVERSION STENTS, 2023-2032 (IN $ MILLION)

FIGURE 24: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY THROMBECTOMY DEVICES, 2023-2032 (IN $ MILLION)

FIGURE 25: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY THROMBECTOMY DEVICES, IN 2022

FIGURE 26: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY CLOT RETRIEVAL DEVICES, 2023-2032 (IN $ MILLION)

FIGURE 27: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY SUCTION AND ASPIRATION DEVICES, 2023-2032 (IN $ MILLION)

FIGURE 28: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY SNARES, 2023-2032 (IN $ MILLION)

FIGURE 29: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY EMBOLIC PROTECTION DEVICES, 2023-2032 (IN $ MILLION)

FIGURE 30: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY EMBOLIC PROTECTION DEVICES, IN 2022

FIGURE 31: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY BALLOON OCCLUSION DEVICES, 2023-2032 (IN $ MILLION)

FIGURE 32: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY DISTAL FILTER DEVICES, 2023-2032 (IN $ MILLION)

FIGURE 33: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2022

FIGURE 34: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY ANEURYSM, 2023-2032 (IN $ MILLION)

FIGURE 35: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY ISCHEMIC STROKE, 2023-2032 (IN $ MILLION)

FIGURE 36: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY STENOSIS, 2023-2032 (IN $ MILLION)

FIGURE 37: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY ARTERIOVENOUS MALFORMATION (AVM), 2023-2032 (IN $ MILLION)

FIGURE 38: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY OTHER APPLICATIONS, 2023-2032 (IN $ MILLION)

FIGURE 39: EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)

FIGURE 40: UNITED KINGDOM NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION)

FIGURE 41: GERMANY NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION)

FIGURE 42: FRANCE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION)

FIGURE 43: ITALY NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION)

FIGURE 44: SPAIN NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION)

FIGURE 45: POLAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION)

FIGURE 46: BELGIUM NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION)

FIGURE 47: REST OF EUROPE NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, 2023-2032 (IN $ MILLION)

FAQ’s

Request Customization
Request Customization
Request free sample